TGFB1 and head and neck squamous cell carcinoma: Examples include increased IFNγ infiltration observed in head and neck squamous cell carcinoma (HNSCC) preclinical models treated with a TGFβ inhibitor-expressing VV, making the tumor more responsive to treatment (156).